Genscript Biotech Corp (GNNSF)
1.05
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Genscript Biotech Enterprise Value: 1.301B for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 1.301B |
| June 13, 2024 | 1.301B |
| June 12, 2024 | 1.301B |
| June 11, 2024 | 1.301B |
| June 10, 2024 | 1.301B |
| June 07, 2024 | 1.301B |
| June 06, 2024 | 1.301B |
| June 05, 2024 | 1.301B |
| June 04, 2024 | 1.301B |
| June 03, 2024 | 1.301B |
| May 31, 2024 | 2.045B |
| May 30, 2024 | 2.045B |
| May 29, 2024 | 2.045B |
| May 28, 2024 | 2.045B |
| May 24, 2024 | 2.045B |
| May 23, 2024 | 2.045B |
| May 22, 2024 | 2.236B |
| May 21, 2024 | 2.234B |
| May 20, 2024 | 2.192B |
| May 17, 2024 | 2.192B |
| May 16, 2024 | 2.192B |
| May 15, 2024 | 2.192B |
| May 14, 2024 | 2.192B |
| May 13, 2024 | 2.192B |
| May 10, 2024 | 2.192B |
| Date | Value |
|---|---|
| May 09, 2024 | 2.192B |
| May 08, 2024 | 2.192B |
| May 07, 2024 | 2.192B |
| May 06, 2024 | 2.192B |
| May 03, 2024 | 2.192B |
| May 02, 2024 | 2.192B |
| May 01, 2024 | 2.192B |
| April 30, 2024 | 2.277B |
| April 29, 2024 | 2.277B |
| April 26, 2024 | 2.255B |
| April 25, 2024 | 2.255B |
| April 24, 2024 | 2.255B |
| April 23, 2024 | 2.255B |
| April 22, 2024 | 2.255B |
| April 19, 2024 | 2.255B |
| April 18, 2024 | 2.255B |
| April 17, 2024 | 2.319B |
| April 16, 2024 | 2.319B |
| April 15, 2024 | 3.317B |
| April 12, 2024 | 3.317B |
| April 11, 2024 | 3.317B |
| April 10, 2024 | 3.317B |
| April 09, 2024 | 3.317B |
| April 08, 2024 | 3.317B |
| April 05, 2024 | 3.317B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.301B
Minimum
Jun 03 2024
10.10B
Maximum
Jul 19 2021
4.529B
Average
4.107B
Median
Nov 29 2022
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -7.011B |
| CASI Pharmaceuticals Inc | 40.60M |
| Zai Lab Ltd | 1.243B |
| Adagene Inc | 30.34M |
| LakeShore Biopharma Co Ltd | 103.96M |
Enterprise Value Related Metrics
| Earnings Yield | -4.31% |
| Normalized Earnings Yield | -5.360 |